23 related articles for article (PubMed ID: 9688432)
1. Statement of Retraction: Mechanism of isosorbide dinitrate combined with exercise training rehabilitation to mobilize endothelial progenitor cells in patients with coronary heart disease.
Bioengineered; 2024 Dec; 15(1):2302652. PubMed ID: 38285907
[No Abstract] [Full Text] [Related]
2. Abrupt cessation of short-term continuous treatment with isosorbide dinitrate may cause a rebound increase in silent myocardial ischaemia in patients with stable angina pectoris.
Martsevich SY; Koutishenko N; Metelitsa VI
Heart; 1996 May; 75(5):447-50. PubMed ID: 8665335
[TBL] [Abstract][Full Text] [Related]
3. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
4. [The possibility of the development of isosorbide dinitrate and nifedipine withdrawal syndromes in patients with stable stenocardia of effort].
Kutishenko NP; Martsevich SIu; Metelitsa VI
Ter Arkh; 1997; 69(9):47-51. PubMed ID: 9411826
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study.
Liang CS; Coplin B; Wellington K
Am J Cardiol; 1985 May; 55(12):9E-14E. PubMed ID: 4003286
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine and isosorbide dinitrate alone and in combination for patients with chronic stable angina: a double-blind crossover study.
Vlay SC; Olson LC
Am Heart J; 1990 Aug; 120(2):303-7. PubMed ID: 2200253
[TBL] [Abstract][Full Text] [Related]
7. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
[TBL] [Abstract][Full Text] [Related]
9. Risk of rebound phenomenon during nitrate withdrawal.
Ferratini M
Int J Cardiol; 1994 Jun; 45(2):89-96. PubMed ID: 7960258
[TBL] [Abstract][Full Text] [Related]
10. The cardiovascular system and daily variation in response to antihypertensive and antianginal drugs: recent advances.
Lemmer B
Pharmacol Ther; 1991; 51(2):269-74. PubMed ID: 1686113
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal effects of antianginal therapy: comparison of isosorbide dinitrate and nifedipine.
Martsevich SYu ; Koutishenko N; Metelitsa VI
Int J Cardiol; 1998 Apr; 64(2):137-44. PubMed ID: 9688432
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
